IRadimed Inventory from 2010 to 2026

46K Stock   83.50  3.00  3.47%   
IRadimed Inventory yearly trend continues to be comparatively stable with very little volatility. Inventory will likely drop to about 6.4 M in 2026. From the period from 2010 to 2026, IRadimed Inventory quarterly data regression had r-value of  0.68 and coefficient of variation of  55.09. View All Fundamentals
 
Inventory  
First Reported
2019-09-30
Previous Quarter
11.2 M
Current Value
11.7 M
Quarterly Volatility
3.4 M
 
Covid
 
Interest Hikes
Check IRadimed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IRadimed's main balance sheet or income statement drivers, such as Tax Provision of 6.1 M, Net Interest Income of 2.6 M or Interest Income of 2.6 M, as well as many indicators such as . IRadimed financial statements analysis is a perfect complement when working with IRadimed Valuation or Volatility modules.
  
This module can also supplement various IRadimed Technical models . Check out the analysis of IRadimed Correlation against competitors.
The evolution of Inventory for IRadimed provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how IRadimed compares to historical norms and industry peers.

Latest IRadimed's Inventory Growth Pattern

Below is the plot of the Inventory of IRadimed over the last few years. It is IRadimed's Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IRadimed's overall financial position and show how it may be relating to other accounts over time.
Inventory10 Years Trend
Slightly volatile
   Inventory   
       Timeline  

IRadimed Inventory Regression Statistics

Arithmetic Mean5,549,302
Geometric Mean5,005,419
Coefficient Of Variation55.09
Mean Deviation2,284,698
Median3,933,987
Standard Deviation3,057,140
Sample Variance9.3T
Range9.2M
R-Value0.68
Mean Square Error5.4T
R-Squared0.46
Significance0
Slope410,176
Total Sum of Squares149.5T

IRadimed Inventory History

20266.4 M
202512 M
202410.4 M
202312.8 M
20225.4 M
20214.3 M
20203.9 M

About IRadimed Financial Statements

IRadimed shareholders use historical fundamental indicators, such as Inventory, to determine how well the company is positioned to perform in the future. Although IRadimed investors may analyze each financial statement separately, they are all interrelated. The changes in IRadimed's assets and liabilities, for example, are also reflected in the revenues and expenses on on IRadimed's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Inventory12 M6.4 M
Change To Inventory2.8 MM

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for IRadimed Stock Analysis

When running IRadimed's price analysis, check to measure IRadimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRadimed is operating at the current time. Most of IRadimed's value examination focuses on studying past and present price action to predict the probability of IRadimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRadimed's price. Additionally, you may evaluate how the addition of IRadimed to your portfolios can decrease your overall portfolio volatility.